Point-of-care Testing (POCT) for Tumor Marker Market size was valued at USD 4.62 Billion in 2024 and is forecasted to grow at a CAGR of 8.2% from 2026 to 2033, reaching USD 9.15 Billion by 2033.
The global Point of Care Testing (POCT) market was valued at approximately USD 38.5 billion in 2022, with a projected compound annual growth rate (CAGR) of around 7% from 2023 to 2032. Within this market, the segment dedicated to tumor marker testing is experiencing significant growth, driven by the increasing prevalence of cancer worldwide and the demand for rapid diagnostic solutions. Although specific figures for the tumor marker POCT segment are limited, it is evident that this niche contributes substantially to the overall market expansion. Regionally, North America dominated the POCT market in 2022, accounting for approximately 47.6% of the total market share, which equates to about USD 18.3 billion. This dominance is attributed to advanced healthcare infrastructure and high adoption rates of innovative diagnostic technologies. Europe follows as a significant market, with countries like Germany and the UK investing heavily in healthcare innovation. The Asia Pacific region is anticipated to exhibit the highest growth rate, with projections estimating a market value of USD 5.75 billion by 2029, growing at a CAGR of 11.2% during the forecast period. This surge is fueled by increasing healthcare awareness, rising cancer incidences, and improving healthcare facilities in countries such as China and India. These trends present substantial opportunities for market players to expand their presence and cater to the growing demand for efficient cancer diagnostics across diverse regions.
Get | Download Sample Copy with TOC, Graphs & List of Figures @ http://verifiedmarketreports.com/download-sample/?rid=358302&utm_source=Google site_G_April&utm_medium=235
Roche
Abbott
BioMerieux
Wondfo Biotech
Yuwell
Getein Biotech
Beijing Wantai BioPharm
Assure Tech
Randox
Orient Gene
Hangzhou Biotest
Shenzhen YHLO
Qingdao Hightop Biotech Co.
Ltd.
Getein Biotech
Inc.
Wuhan Easy Diagnosis Biomedicine Co.
ltd.
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase Of This Report @ https://www.verifiedmarketreports.com/ask-for-discount/?rid=358302&utm_source=Google site_G_April&utm_medium=235
Growing demand for below applications around the world has had a direct impact on the growth of the Global Point-of-care Testing (POCT) for Tumor Marker Market
Immunoassay-based Tests
Microfluidics
Nucleic Acid Tests
Portable Analyzers
Rapid Diagnostic Tests
Prostate-Specific Antigen (PSA)
Alpha-fetoprotein (AFP)
Carcinoembryonic Antigen (CEA)
CA 125
CA 19-9
Others
Oncology
Cardiology
Gastroenterology
Hematology
Others
Hospitals
Specialized Clinics
Home Care Settings
Laboratories
Research Institutions
Electrochemical Detection
Fluorescent Detection
Lateral Flow Technology
Enzyme-linked Immunosorbent Assay (ELISA)
Others
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ https://www.verifiedmarketreports.com/product/point-of-care-testing-poct-for-tumor-marker-market/
1. Introduction of the Global Point-of-care Testing (POCT) for Tumor Marker Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Point-of-care Testing (POCT) for Tumor Marker Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Point-of-care Testing (POCT) for Tumor Marker Market, By Type
6. Global Point-of-care Testing (POCT) for Tumor Marker Market, By Application
7. Global Point-of-care Testing (POCT) for Tumor Marker Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. Global Point-of-care Testing (POCT) for Tumor Marker Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/